Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Research applications Amylin receptor agonism and binding-kinetics assays Satiety and appetite-signalling pathway research Gastric motility and emptying mechanism modelling Energy homeostasis and body-weight pathway investigation Combination studies alongside GLP-1 agonists such as semaglutide Specifications Form: Lyophilised powder Purity: 99% (HPLC verified) Storage: 20C, protected from light and moisture Available sizes: 5mg 10mg Certificate of Analysis: available on request External Reference Research literature
Results: For LDT 1.0, Risk ACE decreased with resmetirom treatment in 21 of 23 subjects, with significant decrease in the mean (0.0182 clinical events per person-year, p=0.0407)
Chronic chemical exposure should be curtailed as much as possible
Scientists also report that local application of BPC-157 may speed up the healing of surgical wounds in rats
